Advertisement

Lung

, Volume 196, Issue 2, pp 185–193 | Cite as

Readmission Due to Exacerbation of COPD: Associated Factors

  • Alicia Cerezo Lajas
  • Enrique Gutiérrez González
  • César Llorente Parrado
  • Luis Puente Maestu
  • Javier de Miguel-Díez
COPD

Abstract

Objectives

To compare characteristics of patients readmitted after discharge by chronic obstructive pulmonary disease (COPD) exacerbation with those who were not readmitted and to identify factors associated with readmission risk.

Patients and Methods

We randomly selected a group of 40 COPD patients with high frequency of readmissions (HFR), who had ≥ 2 admissions by COPD exacerbation within 30 days after the last admission in 2015, and another group of 40 COPD patients with low frequency of readmissions (LFR), with 0–1 admissions in that period.

Results

Patients of the HFR group, compared to those in LFR group, were more frequently males (p = 0.009), older (p = 0.022), had a higher degree of dyspnea (p = 0.044), worse lung function (p = 0.049), belonged more frequently to exacerbator emphysema phenotype (p < 0.001), and had a higher frequency of diabetes (p = 0.049). The variables independently associated with increased risk of HFR were sex (OR 0.06, 95% CI 0.01–0.63, in women in relation to males), exacerbator emphysema phenotype (OR 28.61, 95% CI 3.59 compared to non-exacerbator phenotype), complications during hospitalization (OR 0.09, 95% CI 0.01–0.62, compared with those without complications), destabilized heart failure (OR 5.25, 95% CI 1.11–24.75, compared to those who did not), and length of hospital stay (OR 0.79, 95% CI 0.65–0.95, per day).

Conclusions

Chronic obstructive pulmonary disease patients with HFR are more frequently male, older, have worse dyspnea, lower lung function, belong more frequent to exacerbator emphysema phenotype, and more frequently diabetics. The variables that continued to be independent predictors of HFR in the multivariate analysis were sex, phenotype, occurrence of complications during admission, destabilized heart failure, and length of hospital stay.

Keywords

Pulmonary disease Chronic obstructive Hospitalization Patient discharge Patient readmission 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J et al (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 195:557–582CrossRefPubMedGoogle Scholar
  2. 2.
    Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2017) Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol 53:324–335PubMedGoogle Scholar
  3. 3.
    Escarrabill J, Torrente E, Esquinas C, Hernández C, Monsó E, Freixas M et al (2015) Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 study. Arch Bronconeumol 51:483–489PubMedGoogle Scholar
  4. 4.
    Llauger Roselló MA, Pou MA, Domínguez L, Freixas M, Valverde P, Valero C (2011) Treating COPD in chronic patients in a primary-care setting. Arch Bronconeumol 47:561–570CrossRefPubMedGoogle Scholar
  5. 5.
    Atención integral al paciente con enfermedad pulmonar crónica (EPOC) desde la atención primaria hasta la especializada. Guía de práctica clínica 2010: semFYC/ SEPAR. http://www.guiasalud.es/GPC/GPC_468_EPOC_AP_AE.pdf
  6. 6.
    Calle Rubio M, Morales Chacón B, Rodríguez Hermosa JL (2010) Exacerbation of chronic obstructive pulmonary disease. Arch Bronconeumol 46(Suppl 7):21–25CrossRefPubMedGoogle Scholar
  7. 7.
    Lindenauer PK, Dharmarajan K, Qin L, Lin Z, Gershon AS, Krumholz HM (2017) Risk trajectories of readmission and death in the first year following hospitalization for COPD. Am J Respir Crit Care Med.  https://doi.org/10.1164/rccm.201709-1852OC Google Scholar
  8. 8.
    Nasser R, Epstein D, Azzam R, Gofman I, Saliba W, Hardak E et al (2017) The effect of clinical and physiological instability at discharge following hospitalization for acute exacerbation of COPD on early readmission: a cohort study. Chest 151:1192–1194CrossRefPubMedGoogle Scholar
  9. 9.
    Goto T, Faridi MK, Gibo K, Toh S, Hanania NA, Camargo CA Jr et al (2017) Trends in 30-day readmission rates after COPD hospitalization, 2006–2012. Respir Med 130:92–97CrossRefPubMedGoogle Scholar
  10. 10.
    De Granda-Orive JI, Solano-Reina S (2016) Chronic obstructive pulmonary disease mortality. SEPAR COPD-Smoking year. Arch Bronconeumol 52:407–408PubMedGoogle Scholar
  11. 11.
    McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748–1755CrossRefPubMedGoogle Scholar
  12. 12.
    Vidal García I, Calvo Álvarez U, Lijó Carballeda C, Souto Alonso A, Diego Roza C, Mejuto Martí MJ et al (2012) Características de pacientes con EPOC ingresados por exacerbación en el área sanitaria de Ferrol. Pneuma 8:4–7Google Scholar
  13. 13.
    Sharif R, Parekh TM, Pierson KS, Kuo YF, Sharma G (2014) Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc 11:685–694CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lau CS, Siracuse BL, Chamberlain RS (2017) Readmission after COPD exacerbation scale: determining 30-day readmission risk for COPD patients. Int J Chron Obstruct Pulmon Dis 12:1891–1902CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Roberts MH, Clerisme-Beaty E, Kozma CM, Paris A, Slaton T, Mapel DW (2016) A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulm Med 16:68CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Nishimura K, Izumi T, Tsukino M, Oga T (2002) Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121:1434–1440CrossRefPubMedGoogle Scholar
  17. 17.
    Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Gaude GS, Rajesh BP, Chaudhury A, Hattiholi J (2015) Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India 32:465–472CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shah T, Press VG, Huisingh-Scheetz M, White SR (2016) COPD readmissions: addressing COPD in the era of value-based healthcare. Chest 150:916–926CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Tsoumakidou M, Tzanakis N, Voulgaraki O, Mitrouska I, Chrysofakis G, Samiou M et al (2004) Is there any correlation between the ATS, BTS, ERS and GOLD COPD’s severity scales and the frequency of hospital admissions? Respir Med 98:178–183CrossRefPubMedGoogle Scholar
  21. 21.
    Castillo A, Edriss H, Selvan K, Nugent K (2017) Characteristics of patients with congestive heart failure or chronic obstructive pulmonary disease readmissions within 30 days following an acute exacerbation. Qual Manag Health Care 26:152–159CrossRefPubMedGoogle Scholar
  22. 22.
    Almagro P, Cabrera FJ, Díez J, Boixeda R, Alonso Ortiz MB, Murio C et al (2012) Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 142:1126–1133CrossRefPubMedGoogle Scholar
  23. 23.
    De Miguel Díez J, Gómez García T, Puente Maestu L (2010) Comorbidities in COPD. Arch Bronconeumol 46(Suppl 11):20–25CrossRefPubMedGoogle Scholar
  24. 24.
    González G, Servera E, Ferris G, Blasco ML, Marín J (2004) Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease. Arch Bronconeumol 40:502–507CrossRefPubMedGoogle Scholar
  25. 25.
    Simmering JE, Polgreen LA, Comellas AP, Cavanaugh JE, Polgreen PM (2016) Identifying patients with COPD at high risk of readmission. Chronic Obstr Pulm Dis 3:729–738PubMedPubMedCentralGoogle Scholar
  26. 26.
    Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R et al (2017) The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax 72:686–693CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Alfageme I, Vázquez R, Reyes N, Muñóz J, Fernández A, Hernández M et al (2006) Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 61:189–195CrossRefPubMedGoogle Scholar
  28. 28.
    Lee TA, Weaver FM, Weiss KB (2007) Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 22:62–67CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Schembri S, Morant S, Winter JH, MacDonald TM (2009) Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 64:567–572CrossRefPubMedGoogle Scholar
  30. 30.
    Schenkein JG, Nahm MH, Dransfield MT (2008) Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest 133:767–774CrossRefPubMedGoogle Scholar
  31. 31.
    Jurado Gámez B, Feu Collado N, Jurado García JC, García Gil F, Muñoz Gomariz E, Jiménez Murillo L et al (2013) Intervención domiciliaria y variables predictoras para reingreso hospitalario en la enfermedad pulmonar obstructiva crónica agudizada. Arch Bronconeumol 49:10–14CrossRefPubMedGoogle Scholar
  32. 32.
    Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124:459–467CrossRefPubMedGoogle Scholar
  33. 33.
    Almagro P, Barreiro B, Ochoa de Echaguen A, Quintana S, Rodriguez Carballeira M, Heredia JL (2006) Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 73:311–317CrossRefPubMedGoogle Scholar
  34. 34.
    Villar Álvarez F, Méndez Bailón M, De Miguel Díez J (2009) Chronic obstructive pulmonary disease and heart failure. Arch Bronconeumol 45:387–393CrossRefPubMedGoogle Scholar
  35. 35.
    Echave-Sustaeta J, Comeche Casanova L, García Luján R, Sayas Catalan J, de la Cámara AG, Encuentra AL (2010) Prognosis following acute exacerbation of COPD treated with non-invasive mechanical ventilation. Arch Bronconeumol 46:405–410CrossRefPubMedGoogle Scholar
  36. 36.
    Chu CM, Chan VL, Lin AWN, Wong IWY, Leung WS, Lai CKW (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59:1020–1025CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B et al (2016) Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J 47:113–121CrossRefPubMedGoogle Scholar
  38. 38.
    Maciá Soler L, Latour Pérez J, Moncho Vasallo J, Mariscal Crespo MI, Orts Cortés MI (2011) Modelo de hospitalización y frecuencia de reingreso en pacientes con exacerbación de EPOC. Enferm Glob 10:1–10Google Scholar
  39. 39.
    Sundararajan L, Balami J, Packham S (2010) Effectiveness of outpatient pulmonary rehabilitation in elderly patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 30:121–125CrossRefPubMedGoogle Scholar
  40. 40.
    Williams V, Bruton A, Ellis-Hill C, McPherson K (2010) The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J 19:45–51CrossRefPubMedGoogle Scholar
  41. 41.
    Hansen LO, Young RS, Hinami K, Leung A, Williams MV (2011) Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med 155:520–528CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Alicia Cerezo Lajas
    • 1
  • Enrique Gutiérrez González
    • 2
  • César Llorente Parrado
    • 2
  • Luis Puente Maestu
    • 1
  • Javier de Miguel-Díez
    • 1
    • 3
  1. 1.Respiratory Department, Hospital General Universitario Gregorio Marañón, Facultad de MedicinaUniversidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)MadridSpain
  2. 2.Preventive Medicine Department, Hospital General Universitario Gregorio Marañón, Facultad de MedicinaUniversidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)MadridSpain
  3. 3.Servicio de NeumologíaHospital General Universitario Gregorio MarañónMadridSpain

Personalised recommendations